Publication date: Jul 08, 2025
DelveInsight’s, Parkinson’s Disease Pipeline Insight, 2025 report provides comprehensive insights about 130+ companies and 150+ pipeline drugs in Parkinson’s Disease pipeline landscape. It covers the Parkinson’s Disease pipeline drug profiles, including clinical and nonclinical stage products. It further highlights the inactive pipeline products in this space. Discover the latest drugs and treatment options in the Parkinson’s Disease Pipeline. @ Parkinson’s Disease Pipeline OutlookKey Takeaways from the Parkinson’s Disease Pipeline ReportIn June 2025, Zomagen Biosciences Ltd . It also covers the Parkinson’s Disease pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. announced a study to understand if taking VTX3232 is safe in participants diagnosed with early stage idiopathic Parkinson’s Disease (PD). It has been tested in preclinical models of synuclein-related disease and has shown a reduction of neurodegeneration.
| Concepts | Keywords |
|---|---|
| Biotech | Companies |
| June | Delveinsight |
| Methanesulfonate | Disease |
| Therapy | Drug |
| Vtx3232 | Drugs |
| Parkinson | |
| Pd | |
| Phase | |
| Pipeline | |
| Products | |
| Stage | |
| Therapeutics | |
| Therapies | |
| Treatment |
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | Parkinson’s Disease |
| drug | DRUGBANK | Nonoxynol-9 |
| drug | DRUGBANK | Apomorphine |
| drug | DRUGBANK | Levodopa |
| drug | DRUGBANK | Carbidopa |
| drug | DRUGBANK | Rasagiline |
| drug | DRUGBANK | Levetiracetam |
| drug | DRUGBANK | Rotigotine |
| drug | DRUGBANK | Istradefylline |
| disease | MESH | neuroinflammation |
| disease | MESH | neurodegenerative diseases |
| pathway | REACTOME | Neurodegenerative Diseases |
| drug | DRUGBANK | Isoxaflutole |
| pathway | REACTOME | Dopamine receptors |
| drug | DRUGBANK | Dopamine |
| disease | MESH | dyskinesias |
| disease | MESH | pathogenesis |
| disease | MESH | disease progression |
| drug | DRUGBANK | Lauric Acid |
| disease | MESH | death |
| disease | MESH | chronic diseases |
| disease | MESH | Alzheimer’s disease |
| disease | MESH | hearing loss |